BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Adhoute X, Larrey E, Anty R, Chevallier P, Penaranda G, Tran A, Bronowicki JP, Raoul JL, Castellani P, Perrier H, Bayle O, Monnet O, Pol B, Bourliere M. Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results. World J Clin Cases 2021; 9(18): 4559-4572 [PMID: 34222423 DOI: 10.12998/wjcc.v9.i18.4559]
URL: https://www.wjgnet.com/1007-9327/full/v9/i18/4559.htm
Number Citing Articles
1
Na Zhang, Xiao-Feng He, Xiang-Ke Niu. Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysisWorld Journal of Methodology 2023; 13(4): 345-358 doi: 10.5662/wjm.v13.i4.345
2
Xiang-Ke Niu, Xiao-Feng He. A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular CarcinomaJournal of Personalized Medicine 2022; 12(9): 1375 doi: 10.3390/jpm12091375
3
Apichat Kaewdech, Pimsiri Sripongpun, Suraphon Assawasuwannakit, Panu Wetwittayakhlang, Sawangpong Jandee, Naichaya Chamroonkul, Teerha Piratvisuth. FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): a model to predict intermediate-stage HCC patients who are not good candidates for TACEFrontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1077842
4
Lukas Müller, Felix Hahn, Timo Alexander Auer, Uli Fehrenbach, Bernhard Gebauer, Johannes Haubold, Sebastian Zensen, Moon-Sung Kim, Michel Eisenblätter, Thierno D. Diallo, Dominik Bettinger, Verena Steinle, De-Hua Chang, David Zopfs, Daniel Pinto dos Santos, Roman Kloeckner. Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring SystemsFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.850454